Common anti-inflammatory drug could help prevent skin cancers, S...

Courtesy EurekAlert! - Medicine and Health  Mon, 01/04/2010 - 23:00

(Stanford University Medical Center) A widely-available anti-inflammatory prescription drug can reduce the risk of a common skin cancer in humans, according to a researcher at Stanford's School of Medicine.

Although oral administration of the drug, celecoxib, is associated with an increased risk of heart attack and stroke in some people, it's possible that topical application could have a safer, protective effect for people prone to developing the cancers, called basal cell carcinomas, the researcher believes.


 

More related items

Are EMR's More Secure and Trustworthy Than Paper...
Contrary to utopian praise of EMR's as more secure than paper records:Routine complication from surgery turns fatalLance Williams, Chronicle Staff WriterMonday, August 10, 2009A hospital...

Fluorescent probes may permit monitoring of...
(Stanford University Medical Center) Going out like a brilliant flame is one way to get attention. If physicians could watch tumor cells committing a form of programmed suicide called...

Stanford researchers invent sutureless method for...
(Stanford University Medical Center) Reconnecting severed blood vessels is mostly done the same way today -- with sutures -- as it was 100 years ago, when the French surgeon Alexis Carrel won...

Country Save HE Laundry Detergent, Powder, 160-Load,...

Yogi Tea Calm, Bedtime, Tea Bags, 16-Count Boxes...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com